Surfactant protein D binding to Aspergillus fumigatus hyphae is calcineurin-sensitive

Medical Mycology

Volumn 48, Issue 4, 2010, Pages 580-588

  Geunes Boyer, Scarlett ^a   Heitman, Joseph ^a   Wright, Jo Rae ^a   Steinbach, William J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Aspergillosis; Aspergillus fumigatus; Calcineurin; Hyphae; Surfactant protein D

Indexed keywords

CALCINEURIN; CASPOFUNGIN; NIKKOMYCIN Z; SURFACTANT PROTEIN D; TACROLIMUS;

ARTICLE; ASPERGILLUS FUMIGATUS; CELL WALL; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DRUG PROTEIN BINDING; DRUG SELECTIVITY; DRUG SENSITIVITY; ENZYME INHIBITION; FUNGAL STRAIN; FUNGUS HYPHAE; GENE DELETION; HOST PATHOGEN INTERACTION; INNATE IMMUNITY; NONHUMAN; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; WILD TYPE;

AMINOGLYCOSIDES; ANIMALS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CALCINEURIN; CHO CELLS; CRICETINAE; CRICETULUS; CRYPTOCOCCUS NEOFORMANS; FLOW CYTOMETRY; HUMANS; HYPHAE; LUNG; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; TACROLIMUS;

ASPERGILLUS FUMIGATUS; BACTERIA (MICROORGANISMS);

EID: 77952528236     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693780903401682     Document Type: Article

References (47)

1. Marr KA, Carter RA, Crippa F, et al. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002;34:909-917.
2. McNeil M, Nash S, Hajjeh R, et al. Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997. Clin Infect Dis 2001;33:641-647.
3. Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002;347:408-415. (Pubitemid 34851833)
4. Maertens J, Raad I, Petrikkos G, et al. Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. Clin Infect Dis 2004;39:1563-1571.
5. Araujo R, Rodrigues AG. Variability of germinative potential among pathogenic species of Aspergillus. J Clin Microbiol 2004;42:4335-4337.
6. Rhodes JC. Aspergillus fumigatus: growth and virulence. Med Mycol 2006;44:S77-S81.
7. Wright JR. Immunoregulatory functions of surfactant proteins. Nat Rev Immunol 2005;5:58-68.
8. Giannoni E, Sawa T, Allen L, et al. Surfactant proteins A and D enhance pulmonary clearance of Pseudomonas aeruginosa. Am J Respir Cell Mol Biol 2006;34:704-710.
9. Atochina EN, Gow AJ, Beck JM, et al. Delayed clearance of Pneumocystis carinii infection, increased inflammation, and altered nitric oxide metabolism in lungs of surfactant protein D knockout mice. J Infect Dis 2004;189:1528-1539.
10. LeVine AM, Elliott J, Whitsett JA, et al. Surfactant protein D enhances phagocytosis and pulmonary clearance of respiratory syncytial virus. Am J Respir Cell Mol Biol 2004;31:193-199.
11. Singh M, Madan T, Waters P, et al. Therapeutic effects of recombinant forms of full-length and truncated human surfactant protein D in a murine model of invasive pulmonary aspergillosis. Mol Immunol 2009;46:2363-2369.
12. Reid KB. Structure/function relationships in the collectins (mammalian lectins containing collagen-like regions). Biochem Soc Trans 1993;21:464-468.
13. Madan T, Kishore U, Singh M, et al. Protective role of lung surfactant protein D in a murine model of invasive pulmonary aspergillosis. Infect Immun 2001;69:2728-2731.
14. Klee C, Crouch T, Krinks M. Calcineurin: a calcium- and calmodulinbinding protein of the nervous system. Proc Natl Acad Sci USA 1979;76:6270-6273.
15. Fox D, Heitman J. Good fungi gone bad: the corruption of calcineurin. Bioessays 2002;24:894-903.
16. Clipstone N, Crabtree G. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 1992;357:695-697.
17. Steinbach W, Reedy J, Cramer RJ, et al. Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections. Nat Rev Microbiol 2007;5:418-430.
18. Steinbach WJ, Cramer Jr RA, Perfect BZ, et al. Calcineurin controls growth, morphology, and pathogenicity in Aspergillus fumigatus. Eukaryot Cell 2006;5:1091-1103.
19. Steinbach WJ, Cramer RAJ, Perfect BZ, et al. Calcineurin inhibition or mutation enhances cell wall inhibitors against Aspergillus fumigatus. Antimicrob Agents Chemother 2007;51:2979-2981.
20. Hohl T, Feldmesser M, Perlin D, et al. Caspofungin modulates inflammatory responses to Aspergillus fumigatus through stage-specific effects on fungal beta-glucan exposure. J Infect Dis 2008;198:176-185.
21. Lamaris G, Lewis R, Chamilos G, et al. Caspofungin-mediated betaglucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae. J Infect Dis 2008;198:186-192.
22. Dong Q, Wright J. Degradation of surfactant protein D by alveolar macrophages. Am J Physiol 1998;274:L97-105.
23. Brinker K, Martin E, Borron P, et al. Surfactant protein D enhances bacterial antigen presentation by bone marrow-derived dendritic cells. Am J Physiol Lung Cell Mol Physiol 2001;281:L1453-1463.
24. Brinker K, Garner H, Wright J. Surfactant protein A modulates the differentiation of murine bone marrow-derived dendritic cells. Am J Physiol Lung Cell Mol Physiol 2003;284:L232-241.
25. Kojima K, Bahn Y, Heitman J. Calcineurin, Mpk1 and Hog1 MAPK pathways independently control fludioxonil antifungal sensitivity in Cryptococcus neoformans. Microbiology 2006;152:591-604.
26. Geunes-Boyer S, Oliver T, Janbon G, et al. Surfactant protein D increases phagocytosis of hypocapsular Cryptococcus neoformans by murine macrophages and enhances fungal survival. Infect Immun 2009;77:2783-2794.
27. James S, Mirabito P, Scacheri P, et al. The Aspergillus nidulans bimE (blocked-in-mitosis) gene encodes multiple cell cycle functions involved in mitotic checkpoint control and mitosis. J Cell Sci 1995;108:3485-3499.
28. Allen MJ, Voelker DR, Mason RJ. Interactions of surfactant proteins A and D with Saccharomyces cerevisiae and Aspergillus fumigatus. Infect Immun 2001;69:2037-2044.
29. Madan T, Eggleton P, Kishore U, et al. Binding of pulmonary surfactant proteins A and D to Aspergillus fumigatus conidia enhances phagocytosis and killing by human neutrophils and alveolar macrophages. Infect Immun 1997;65:3171-3179.
30. Schelenz S, Malhotra R, Sim RB, et al. Binding of host collectins to the pathogenic yeast Cryptococcus neoformans: human surfactant protein D acts as an agglutinin for acapsular yeast cells. Infect Immun 1995;63:3360-3366.
31. Fortwendel J, Juvvadi P, Pinchai N, et al. Differential effects of inhibiting chitin and 1, 3-{beta}-D-glucan synthesis in ras and calcineurin mutants of Aspergillus fumigatus. Antimicrob Agents Chemother 2009;53:476-482.
32. Allen M, Voelker D, Mason R. Interactions of surfactant proteins A and D with Saccharomyces cerevisiae and Aspergillus fumigatus. Infect Immun 2001;69:2037-2044.
33. Allen M, Laederach A, Reilly P, et al. Polysaccharide recognition by surfactant protein D: novel interactions of a C-type lectin with nonterminal glucosyl residues. Biochemistry 2001;40:7789-7798.
34. Crouch E, McDonald B, Smith K, et al. Contributions of phenylalanine 335 to ligand recognition by human surfactant protein D: ring interactions with SP-D ligands. J Biol Chem 2006;281:18008-18014.
35. Crouch E, Smith K, McDonald B, et al. Species differences in the carbohydrate binding preferences of surfactant protein D. Am J Respir Cell Mol Biol 2006;35:84-94.
36. Cramer RAJ, Perfect BZ, Pinchai N, et al. The calcineurin target CrzA regulates conidial germination, hyphal growth and pathogenesis of Aspergillus fumigatus. Eukaryot Cell 2008;7:1085-1097.
37. Brummer E, Stevens D. Collectins and fungal pathogens: roles of surfactant proteins and mannose binding lectin in host resistance. Med Mycol [10.1080/13693780903117473] 2009:1-13. Available from: http://www.informaworld. com/smpp/content~db=all?content=10.108 0/13693780903117473
38. Kozel T, Gotschlich E. The capsule of Cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages. J Immunol 1982;129:1675-1680.
39. van de Wetering J, Coenjaerts F, Vaandrager A, et al. Aggregation of Cryptococcus neoformans by surfactant protein D is inhibited by its capsular component glucuronoxylomannan. Infect Immun 2004;72:145-153.
40. Lekkala M, LeVine A, Linke M, et al. Effect of lung surfactant collectins on bronchoalveolar macrophage interaction with Blastomyces dermatitidis: inhibition of tumor necrosis factor alpha production by surfactant protein D. Infect Immun 2006;74:4549-4556.
41. Chang Y, Kwon-Chung K. Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence. Mol Cell Biol 1994;14:4912-4919.
42. Lawson P, Perkins V, Holmskov U, et al. Genomic organization of the mouse gene for lung surfactant protein D. Am J Respir Cell Mol Biol 1999;20:953-963.
43. Lu J, Willis A, Reid K. Purification, characterization and cDNA cloning of human lung surfactant protein D. Biochem J 1992;284:795-802.
44. Motwani M, White R, Guo N, et al. Mouse surfactant protein D. cDNA cloning, characterization, and gene localization to chromosome 14. J Immunol 1995;155:5671-5677.
45. Hartshorn K, Chang D, Rust K, et al. Interactions of recombinant human pulmonary surfactant protein D and SP-D multimers with influenza A. Am J Physiol 1996;271:L753-762.
46. Allen M, Harbeck R, Smith B, et al. Binding of rat and human surfactant proteins A and D to Aspergillus fumigatus conidia. Infect Immun 1999;67:4563-4569.
47. Latge JP, Mouyna I, Tekaia F, et al. Specific molecular features in the organization and biosynthesis of the cell wall of Aspergillus fumigatus. Med Mycol 2005;43:S15-22.